Anastasios Koutsopoulos

Author

Also Known As

A Koutsopoulos, A V Koutsopoulos, A. Koutsopoulos, A. V. Koutsopoulos, A.V. Koutsopoulos, Anastasios Koutsopoulos, Anastasios V Koutsopoulos, Anastasios V. Koutsopoulos, Anastasis Koutsopoulos, Anastassios Koutsopoulos

108

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Crete University Hospital of Heraklion Democritus University of Thrace University Hospital of Alexandroupolis National and Kapodistrian University of Athens

About

Anastasios Koutsopoulos is an author at University of Crete specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	960
2	Cell Biology	5	5	162
3	Health Sciences	1	1	14
4	Public Health	1	1	19
5	Biochemistry	1	1	43

Anastasios Koutsopoulos

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC Aristea Kalikaki, Anastasios Koutsopoulos, Maria Trypaki, British Journal of Cancer	2008	207
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts Dimitra Kerdidani, Emmanouil Aerakis, Kleio‐Maria Verrou, The Journal of Experimental Medicine HistocompatibilityLung InflammationT-regulatory CellImmunologyImmunoediting	2021	170
Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients Ioannis Boukovinas, Chara Papadaki, Pedro Méndez, PLoS ONE	2008	124
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine John Souglakos, Ioannis Boukovinas, Miquel Tarón, British Journal of Cancer Tumor BiologyOncogenic AgentMedicineLung Adenocarcinoma PatientsQuantitative Real-time Pcr	2008	117
‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer Athanasios Pallis, Alexandra Voutsina, Ar Kalikaki, British Journal of Cancer Kinase InhibitorsPathologyCancer BiologyTumor BiologyClassical Exon	2007	92
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status Aristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki, Lung Cancer MedicinePathologyK-ras Mutation StatusFront-line ChemotherapyBronchial Neoplasm	2009	88
Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer Maria A. Papadaki, Anastasios Koutsopoulos, Panormitis G Tsoulfas, Cancers	2020	87
<i><scp>PIK</scp>3<scp>CA</scp></i> hotspot mutations in circulating tumor cells and paired circulating tumor <scp>DNA</scp> in breast cancer: a direct comparison study Eleni Tzanikou, Athina Markou, Eleni Politaki, Molecular Oncology	2019	80
Effects of respiratory rate on ventilator-induced lung injury at a constant Paco2 in a mouse model of normal lung Katerina Vaporidi, George Priniannakis, Εumorfia Kondili, Critical Care Medicine	2008	74
High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas Alexandra Giatromanolaki, Michael I. Koukourakis, Anastasios Koutsopoulos, Gynecologic Oncology Tumor BiologyEndometrial AdenocarcinomasMedicineGynecologyPathology	2011	73

Page 1